1

Postdoctoral Rna Therapeutics Jobs (NOW HIRING)

next page

Showing results 1-20

Postdoctoral Rna Therapeutics information

See salary details

$25K

$59K

$83.5K

How much do postdoctoral rna therapeutics jobs pay per year?

As of Jun 6, 2026, the average yearly pay for postdoctoral rna therapeutics in the United States is $59,022.00, according to ZipRecruiter salary data. Most workers in this role earn between $49,000.00 and $66,500.00 per year, depending on experience, location, and employer.

What is the difference between Postdoctoral Rna Therapeutics vs Postdoctoral Molecular Biology?

AspectPostdoctoral Rna TherapeuticsPostdoctoral Molecular Biology
Required CredentialsPhD in Molecular Biology, Biochemistry, or related fieldPhD in Molecular Biology, Biochemistry, or related field
Work EnvironmentResearch labs focused on RNA-based therapies, biotech or pharma companiesAcademic or industry labs working on gene expression, protein function, or cellular processes
Employer & Industry UsageBiotech, pharmaceutical companies, research institutes specializing in RNA therapeutics

Postdoctoral Rna Therapeutics and Postdoctoral Molecular Biology share similar educational backgrounds and work environments. However, Rna Therapeutics focuses specifically on developing RNA-based treatments, while Molecular Biology covers broader cellular and genetic research. The choice depends on your interest in applied therapeutic development versus fundamental biological research.

What are the key skills and qualifications needed to thrive as a Postdoctoral RNA Therapeutics researcher, and why are they important?

To thrive as a Postdoctoral RNA Therapeutics researcher, you need a PhD in molecular biology, biochemistry, or a related field, with strong expertise in RNA biology and therapeutic development. Experience with technical tools such as CRISPR, qPCR, next-generation sequencing, and bioinformatics platforms is highly valued. Critical thinking, problem-solving, and strong collaboration skills help you design experiments and work effectively within multidisciplinary teams. These competencies are crucial for advancing RNA-based therapies from basic research to clinical applications.

What are some common challenges faced by Postdoctoral researchers in RNA therapeutics, and how can they be addressed?

Postdoctoral researchers in RNA therapeutics often encounter challenges such as optimizing complex experimental protocols, staying current with rapidly evolving technologies, and navigating the interdisciplinary nature of the field. Collaborating closely with experts in molecular biology, chemistry, and bioinformatics can help address technical hurdles. Additionally, participating in regular lab meetings, attending specialized workshops, and seeking mentorship are effective strategies to overcome obstacles and foster professional growth in this dynamic research area.

What are Postdoctoral RNA Therapeutics researchers?

Postdoctoral RNA Therapeutics researchers are scientists who have completed their doctoral studies and are conducting advanced research focused on RNA-based therapies. Their work often involves designing, developing, and testing RNA molecules, such as siRNA, mRNA, or antisense oligonucleotides, to treat various diseases. They typically work in academic institutions, research hospitals, or the biotechnology industry, collaborating on projects that aim to translate findings from basic science into clinical applications. Their role is crucial in advancing the field of RNA medicine and contributing to the development of innovative treatments.
Infographic showing various Postdoctoral Rna Therapeutics job openings in the United States as of May 2026, with employment types broken down into 100% Full Time. Highlights an 100% In-person job distribution, with an average salary of $59,022 per year, or $28.4 per hour.
Senior Scientist, Drug Metabolism & Pharmacokinetics (DMPK)

Senior Scientist, Drug Metabolism & Pharmacokinetics (DMPK)

Prime Medicine

Cambridge, MA

$107K - $137K/yr

Other

Posted 11 days ago


Job description

Position Overview

We are seeking a motivated and skilled Senior Scientist to join the Nonclinical Development group, contributing to the DMPK function in support of exploratory and IND-enabling programs across Prime Medicine's pipeline. Reporting to the Associate Director, DMPK/Bioanalytical Sciences, this individual will independently analyze and interpret datasets from in vivo studies, contribute to nonclinical regulatory documents, and work cross-functionally with pharmacology, translational biology and external CROs, to ensure high-quality DMPK data packages are delivered to support program timelines. The ideal candidate has a strong foundation in in vivo pharmacokinetics for RNA therapeutics and/or LNP-based delivery systems, thrives in a fast-paced and matrixed organization, and possesses the flexibility and positive attitude needed to make meaningful contributions to the Nonclinical Development team.

Primary Responsibilities
  • Analyze and interpret PK study data from exploratory and IND-enabling in vivo
  • Perform non-compartmental analysis (NCA) using Phoenix WinNonlin to derive key PK parameters (Cmax, AUC, T, Vd, CL).
  • Leverage expertise in DMPK to provide recommendations for in vivo study designs in collaboration with pharmacology and key stakeholders.
  • Perform bioanalytical assay development (30%) and collaborate with bioanalytical scientists to trouble-shoot challenges during method development to ensure quantitative methods for key analytes (LNP lipid components, mRNA, pegRNA, PD biomarkers) meet regulatory expectations and data quality standards..
  • Contribute to nonclinical regulatory documents including pharmacokinetics summaries and nonclinical study reports under the guidance of senior stakeholders in Nonclinical Development.
  • Maintain thorough records in the electronic laboratory notebook (ELN); prepare clear data summaries, presentations, and technical memos for program team and governance meetings.
Qualifications

Minimum Qualifications

  • D. in pharmacokinetics, pharmaceutical sciences, pharmacology, biochemistry, or a related discipline.
  • 6+ years of cumulative experience. Industry experience (biotech or pharmaceutical) with direct responsibility for in vivo DMPK study design, execution, and interpretation is required; postdoctoral training in a DMPK or translational pharmacology setting is strongly preferred
  • Demonstrated experience with in vivo PK studies in preclinical models and proficiency in NCA using Phoenix WinNonlin or equivalent software.
  • Familiarity with regulatory expectations for nonclinical DMPK assessments and bioanalytical assay development.
  • Demonstrated ability to coordinate with external CROs, including scientific guidance, protocol development, and data review..
  • Strong written and verbal communication skills; ability to present complex DMPK data clearly to multidisciplinary audiences.
  • Highly self-motivated, collaborative, and organized, with the ability to manage multiple priorities independently in a fast-paced matrix environment.

Preferred Qualifications

  • Familiarity with PK/PD modeling concepts; experience with Phoenix WinNonlin modeling modules a plus.
  • Experience with LNP-based delivery systems and/or RNA therapeutics (mRNA, siRNA, ASO, sgRNA or related modalities).
  • Experience with exploratory DMPK studies, evaluating new delivery vehicles and evaluation of biodistribution using in vivo
  • Familiarity with bioanalytical platforms supporting DMPK studies, including LC-MS/MS, RT-qPCR/ddPCR, ELISA/MSD.
  • Ability and excitement to contribute to the development and success of the Nonclinical Development team.